Blood Meal-Derived Heme Decreases ROS Levels in the Midgut of Aedes aegypti and Allows Proliferation of Intestinal Microbiota

The presence of bacteria in the midgut of mosquitoes antagonizes infectious agents, such as Dengue and Plasmodium, acting as a negative factor in the vectorial competence of the mosquito. Therefore, knowledge of the molecular mechanisms involved in the control of midgut microbiota could help in the development of new tools to reduce transmission. We hypothesized that toxic reactive oxygen species (ROS) generated by epithelial cells control bacterial growth in the midgut of Aedes aegypti, the vector of Yellow fever and Dengue viruses. We show that ROS are continuously present in the midgut of sugar-fed (SF) mosquitoes and a blood-meal immediately decreased ROS through a mechanism involving heme-mediated activation of PKC. This event occurred in parallel with an expansion of gut bacteria. Treatment of sugar-fed mosquitoes with increased concentrations of heme led to a dose dependent decrease in ROS levels and a consequent increase in midgut endogenous bacteria. In addition, gene silencing of dual oxidase (Duox) reduced ROS levels and also increased gut flora. Using a model of bacterial oral infection in the gut, we show that the absence of ROS resulted in decreased mosquito resistance to infection, increased midgut epithelial damage, transcriptional modulation of immune-related genes and mortality. As heme is a pro-oxidant molecule released in large amounts upon hemoglobin degradation, oxidative killing of bacteria in the gut would represent a burden to the insect, thereby creating an extra oxidative challenge to the mosquito. We propose that a controlled decrease in ROS levels in the midgut of Aedes aegypti is an adaptation to compensate for the ingestion of heme.

Epidemiology and antimicrobial resistance of B. fragilis group organisms isolated from clinical specimen and human intestinal microbiota

Epidemiological aspects and the antimicrobial susceptibility profile of the Bacteroides fragilis group isolated from clinical and human intestinal specimens were examined in this study. B. fragilis group strains were isolated from 46 (37%) of 124 clinical specimens and the source of the samples was: Blood culture (3), intraabdominal infection (27), brain abscess (2), soft tissue infection (17), respiratory sinus (3), pleural aspirate (9), breast abscess (3), surgical infected wound (22), pelvic inflammatory disease (22), chronic otitis media (9) and miscellaneous (7). Intraabdominal and soft tissue infections were responsible for more than half of the clinical isolates. Susceptibility to penicillin, cefoxitin, tetracycline, metronidazole, chloramphenicol and clindamycin was examined. All isolates were susceptible to metronidazole and chloramphenicol. For clindamycin and cefoxitin the resistance rates observed were 21.7% and 10.9% respectively. Susceptibility profiles varied among the different species tested. A total of 37 species of B. fragilis group isolated from intestinal microbiota of individuals who had no antimicrobial therapy for at least 1 month before the sampling was also examined. All strains were also susceptible to chloramphenicol and motronidazole and the resistance rates to clindamycin and cefoxitin were 19.4% and 5.4% respectively. A few institutions, in Brazil, have monitored the antimicrobial susceptibility of B. fragilis group strains isolated from anaerobic infections. The resistance rates to cefoxitin and clindamycin and the variation in susceptibility patterns among the species isolated in this study emphasize the need for monitoring of susceptibility patterns of B. fragilis group organisms isolated, especially at our University Hospitals.

The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation.

Intestinal helminths are potent regulators of their host's immune system and can ameliorate inflammatory diseases such as allergic asthma. In the present study we have assessed whether this anti-inflammatory activity was purely intrinsic to helminths, or whether it also involved crosstalk with the local microbiota. We report that chronic infection with the murine helminth Heligmosomoides polygyrus bakeri (Hpb) altered the intestinal habitat, allowing increased short chain fatty acid (SCFA) production. Transfer of the Hpb-modified microbiota alone was sufficient to mediate protection against allergic asthma. The helminth-induced anti-inflammatory cytokine secretion and regulatory T cell suppressor activity that mediated the protection required the G protein-coupled receptor (GPR)-41. A similar alteration in the metabolic potential of intestinal bacterial communities was observed with diverse parasitic and host species, suggesting that this represents an evolutionary conserved mechanism of host-microbe-helminth interactions.

Intestinal microbiota in the adenoma progression to colorectal cancer: a cross-sectional study

Background: Colorectal cancer is a major health problem worldwide and many efforts have been done to delineate risk factors and develop screening strategies to reduce its incidence and mortality. Colorectal adenomas have been clearly considered preneoplastic lesions due to their potential malignant transformation via the adenoma-carcinoma sequence. Over the last years, intestinal microbiota has been studied in several diseases and it has been hypothesized that colonic microbiota could influence colorectal cancer pathogenesisObjective: The goal of this study is to analyse whether there is an association between the fecal microbiota profiling and the presence and progression of colorectal adenomas, detected in population undergoing colonoscopy, to better understand the role of intestinal microbiota in colorectal carcinogenesisDesign: A cross-sectional study in the Gastroenterology Department at Hospital Universitari Doctor Josep Trueta in Girona, in a period of time of two yearsParticipants: General population undergoing screening or diagnostic colonoscopy in the Digestive Endoscopy UnitOutcomes: Identification and characterization of intestinal microbiota in stool samples from healthy patients and patients with low and high risk colorectal adenomas

Early Life Intestinal Microbiota in Health and in Atopic Eczema

Decrease in microbial contacts in affluent societies is considered to lie behind the rise in allergic and other chronic inflammatory diseases during the last decades. Indeed, deviations in the intestinal microbiota composition and diversity have been associated with several diseases, such as atopic eczema. However, there is no consensus yet on what would constitute a beneficial or harmful microbiota. The aim of this thesis was to study the microbiota development in healthy infants and to characterize intestinal microbiota signatures associated with disease status and severity in infants with atopic eczema. The methodological aim was to compare and optimize methods for DNA extraction from fecal samples to be used in high-throughput microbiota analyses. It was confirmed that the most critical step in successful microbial DNA extraction from fecal samples is the mechanical cell lysis procedure. Based on this finding, an efficient semi-automated extraction process was developed that can be scaled for use in high-throughput platforms such as phylogenetic microarray used in this series of studies. By analyzing a longitudinal motherchild cohort for 3 years it was observed that the microbiota development is a gradual process, where some bacterial groups reach the degree of adult-type pattern earlier than others. During the breast-feeding period, the microbiota appeared to be relatively simple, while major diversification was found to start during the weaning process. By the age of 3 years, the child’s microbiota composition started to resemble that of an adult, but the bacterial diversity has still not reached the full diversity, indicating that the microbiota maturation extends beyond this age. In addition, at three years of age, the child’s microbiota was more similar to mother’s microbiota than to microbiota of nonrelated women.In infants with atopic eczema, a high total microbiota diversity and abundance of butyrate-producing bacteria was found to correlate with mild symptoms at 6 months. At 18 months, infants with mild eczema had significantly higher microbiota diversity and aberrant microbiota composition when compared to healthy controls at the same age. In conclusion, the comprehensive phylogenetic microarray analysis of early life microbiota shows the synergetic effect of vertical transmission and shared environment on the intestinal microbiota development. By the age of three years, the compositional development of intestinal microbiota is close to adult level, but the microbiota diversification continues beyond this age. In addition, specific microbiota signatures are associated with the existence and severity of atopic eczema and intestinal microbiota seems to have a role in alleviating the symptoms of this disease.

Effects of tubers of the Jerusalem artichoke (Helianthus tuberosus) and potatoes (Solanum tuberosum) on the intestinal microbiota of pigs and evaluation of a procedure for quantification of microbial mass in pig faeces

Die Mikrobiota im Gastrointestinaltrakt (GIT) spielt eine bedeutende Rolle beim Fermentationsprozess im Bezug auf die Nährstoffversorgung sowie die Gesundheit des Darms und des gesamten Organismus. Inulin und resistente Stärke (RS) konnten als präbiotisch wirksame Substanzen identifiziert werden und sind jeweils auch in den Knollen der Topinamburpflanze (Helianthus tuberosus) und in Kartoffeln (Solanum tuberosum) enthalten. Da sie ebenfalls energiereiche Futtermittel für Schweine sind, war es das Ziel der ersten beiden Studien, die Auswirkungen der Aufnahme von Topinamburknollen und Kartoffeln auf die intestinale Mikrobiota und Parameter des Immunsystems bei Endmastschweinen zu bestimmen. In der dritten Studie wurde die mikrobielle Biomasse quantitativ mit einem Verfahren zur Isolation von Bakterien in einer Flüssigkeit durch Hochgeschwindigkeits-Zentrifugation erfasst und der bakteriell gebundene Stickstoff (MP-N) mit dem bakteriellen und endogenem Kotstickstoff (BEDN) verglichen. Im ersten Versuch wurden 72 Endmastschweine in einem Freilandhaltungssystem in eine Kontroll- (CT), die mit Kraftfutter entsprechend des Bedarfs der Tiere für ein Leistungsniveau von 700 g täglichem Lebendmassezuwachs versorgt wurde, und eine Versuchsvariante (ET) aufgeteilt. In der Versuchsvariante erhielten die Tiere nur 70% der Kraftfuttermenge der Kontrollvariante, hatten aber Zugang zu einer abgeteilten Fläche, auf der Topinamburknollen angebaut waren. Die freie Aufnahme von Topinamburknollen wurde auf 1•24 kg Trockenmasse (TM)/Tag bestimmt, entsprechend einer Inulinaufnahme von durchschnittlich 800 g/Tag. Während sich die Wachstumsleistung in der Kontrollvariante auf 0•642 ± 0•014 kg/Tag belief, war sie in der Versuchsvariante mit 0•765 ± 0•015 kg/Tag (P=0•000) höher. Die freie Verfügbarkeit von Inulin und Fructo-oligosacchariden (FOS) im GIT der Schweine erhöhte die Keimzahlen der anaeroben Bakterien (P=0•000), Laktobazillen (P=0•046) und Hefen (P=0•000) signifikant und verringerte das Vorkommen von Clostridium perfringens im Schweinekot erheblich von lg 5•24 ± 0•17 kolonie-bildende Einheiten pro g Frischmasse (KbE/ g FM) in der Kontrollvariante auf lg 0•96 ± 0•20 KbE/ g FM in der Versuchsvariante (P=0•000). C-reaktives Protein (CRP) und Antikörper gegen Lipopolysaccharide (LPS) von Escherichia coli J5 ließen keine Unterschiede zwischen den Fütterungsvarianten erkennen. In der zweiten Untersuchung wurden 58 Endmastschweine einer Kontrollvariante (CT), die bedarfsgerecht mit einer Kraftfuttermischung für ein Leistungsniveau von 700 g Tageszunahmen gefüttert wurde, und zwei Versuchsvarianten zugeteilt. Die Versuchsvarianten erhielten eine Menge von 1•2 kg TM gedämpften Kartoffeln (potato treatment, PT) oder gedämpften und einsilierten Kartoffeln (silage treatment, ST) pro Tag und nur 46% bzw. 43% der Menge des Kraftfutters der Kontrollvariante. Die Wachstumsleistung und Schlachtkörperzusammensetzung ließen keine signifikanten Unterschiede zwischen den Varianten erkennen. Im PT und ST waren gegenüber dem CT im Kot der pH-Wert sowie die Gehalte von TM, Neutral-Detergenz-Faser (NDF), unverdautem Futterstickstoff (UDN) und teilweise von Säure-Detergenz-Faser (ADF) signifikant niedriger (P=0•000) und die von Ammonium (NH4) und Ammoniumstickstoff (NH4-N) signifikant höher (P=0•000). Das hohe Angebot von hitzebehandelten Kartoffeln führte zu einer erheblichen Verringerung von E. coli (P=0•000), C. perfringens (P=0•000) und Immunoglobulin A gegen LPS von E. coli J5 (P=0•001). Darüber hinaus waren in der ersten Versuchsperiode im ST die aeroben und anaeroben Gesamtkeimzahlen sowie die Laktobazillen und Hefen gegenüber dem PT signifikant erhöht. Die Unterschiede in der Mikrobiota zwischen der Kontroll- und Versuchsvarianten weisen auf die positiven Auswirkungen von Topinamburknollen und hitzebehandelten Kartoffeln auf die Mikrobiota im hinteren Darmabschnitt hin. Das Ziel der dritten Untersuchung war die Modifizierung des Verfahrens zur Isolation von Bakterien in einer Flüssigkeit mittels verschiedener Zentrifugationsschritte, um ein mikrobielles Pellet (MP) zu erhalten, welches die quantitative Abtrennung und Erfassung der Bakterien in Schweinekot ermöglicht. Zusätzlich wurde der BEDN Anteil sowie die Gehalte der Aminozucker Galactosamin, Glucosamin, Mannosamin und Muraminsäure im Kot und im MP bestimmt. Die untersuchten Kotproben stammten von Schweinen eines Phosphor (P) Stoffwechselversuch. Zehn männlich-kastrierte Schweine mit einem durchschnittlichen Lebendgewicht von 51•1 ± 8•5 kg wurden einzeln in Stoffwechselkäfigen gehalten. Die Tiere wurden fünf Fütterungsvarianten zugeteilt, die dem Bedarf der Tiere für ein Leistungsniveau von 700 g Tageszunahmen entsprachen, in den Rationen 2 bis 5 jedoch eine P-Gehalt unter dem Tagesbedarf der Tiere aufwiesen und in den Rationen 3 bis 5 mit abgestuften Gehalten von 50, 100 sowie 200 mg/kg einer experimentellen Phytase ergänz waren. Die Absenkung des P Gehaltes im Futter verringerte den Asche- (P=0•024) und Trockenmassegehalt im Kot (P=0•017) sowie die P Konzentration im MP (P=0•000) signifikant. Die mikrobielle Biomasse im Kot wurde durch die Wiegung des MP auf durchschnittlich 467 g/kg TM bestimmt. Der Stickstoffgehalt im Kot betrug im Mittel 46•1 g/kg TM und der in die Bakterienmasse eingebaute Stickstoffanteil 27•1 g/kg TM bzw. 58% vom Gesamtstickstoffgehalt im Kot. Die BEDN Fraktion wurde auf 73% am Kotstickstoff bestimmt. Der P-Gehalt im Kot sowie der N Gehalt im MP mit durchschnittlichen 10•4 und 57•9 g/kg TM lagen im Bereich von Literaturangaben. Die P Gehalte im MP schwankten in Abhängigkeit von der Zugabe von Phytase signifikant (P=0•000) von 1•8 bis 4•8 g/kg TM. Die Aminozucker wiesen keine signifikanten unterschiede zwischen Fütterungsvarianten auf und lagen im Bereich von Werten von Rinderkot. Ergebnisse weisen darauf hin, dass die angewandte Methode zur direkten Quantifizierung der mikrobiellen Biomasse geeignet ist.

The effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy

The effects of probiotic supplementation on the intestinal re-growth microbiota following antibiotic therapy were studied in a double-blind placebo-controlled study. In the placebo group, numbers of facultative anaerobes and enterobacteria increased significantly, and at day 35 the numbers were significantly higher in the placebo group than in the active group; in the active group, the numbers of bacteroides increased significantly. Although the numbers of enterococci in both groups did not change, in the placebo group the number of patients harbouring antibiotic-resistant enterococci post therapy increased significantly. There was no change in the incidence rate of antibiotic resistance among the patients in the probiotic group.

The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota.

We have examined the gut bacterial metabolism of pomegranate by-product (POMx) and major pomegranate polyphenols, punicalagins, using pH-controlled, stirred, batch culture fermentation systems reflective of the distal region of the human large intestine. Incubation of POMx or punicalagins with faecal bacteria resulted in formation of the dibenzopyranone-type urolithins. The time course profile confirmed the tetrahydroxylated urolithin D as the first product of microbial transformation, followed by compounds with decreasing number of phenolic hydroxy groups: the trihydroxy analogue urolithin C and dihydroxylated urolithin A. POMx exposure enhanced the growth of total bacteria, Bifidobacterium spp. and Lactobacillus spp., without influencing the Clostridium coccoides–Eubacterium rectale group and the C. histolyticum group. In addition, POMx increased concentrations of short chain fatty acids (SCFA) viz. acetate, propionate and butyrate in the fermentation medium. Punicalagins did not affect the growth of bacteria or production of SCFA. The results suggest that POMx oligomers, composed of gallic acid, ellagic acid and glucose units, may account for the enhanced growth of probiotic bacteria.

Changes in the intestinal microbiota after a short period of dietary over-indulgence, representative of a holiday or festival season

The effects on the intestinal microbiota of a short period of marginal over-eating, characteristic of holiday or festival periods, were investigated in a pilot study. Fourteen healthy male subjects consumed a diet rich in animal protein and fat for seven days. During this period, the subjects significantly increased their dietary energy, protein, carbohydrate and fat intakes by 56, 59, 53 and 58%, respectively (all P < 0.05). The mean weight gain of 0.27 kg was less than the expected 1 kg, but this was consistent with a degree of under-reporting on the baseline diet. Fluorescence in situ hybridisation analysis confirmed the relative stability of each individual’s faecal microbiota but showed considerable variations between them. The diet was associated with a significant increase in numbers of total faecal bacteria and the bacteroides group, as detected by the universal bacterial probe (DAPI) and Bacteroides probe (Bac 303), respectively. Overall, there was a decrease in numbers of the Lactobacillus/Enterococcus group (Lab 158 probe; 2.8 ± 3.0% to 1.8 ± 1.8%) and the Bifidobacterium group (Bif 164 probe; 3.0 ± 3.7% to 1.7 ± 1.2%), although there was considerable inter-individual variation. Analysis of the relative proportions of each bacterial group as a percentage of the subject’s total bacteria showed a trend for a change in the intestinal microbiota that might be considered potentially unhealthy.

Neonatal environment exerts a sustained influence on the development of the intestinal microbiota and metabolic phenotype

The postnatal environment, including factors such as weaning and acquisition of the gut microbiota, has been causally linked to the development of later immunological diseases such as allergy and autoimmunity, and has also been associated with a predisposition to metabolic disorders. We show that the very early-life environment influences the development of both the gut microbiota and host metabolic phenotype in a porcine model of human infants. Farmpiglets were nursed by their mothers for 1 day, before removal to highly controlled, individual isolators where they received formula milk until weaning at 21 days. The experiment was repeated, to create two batches, which differed only in minor environmental fluctuations during the first day. At day 1 after birth, metabolic profiling of serum by 1H nuclear magnetic resonance spectroscopy demonstrated significant, systemic, inter-batch variation which persisted until weaning. However, the urinary metabolic profiles demonstrated that significant inter-batch effects on 3-hydroxyisovalerate, trimethylamine-N-oxide and mannitol persisted beyond weaning to at least 35 days. Batch effects were linked to significant differences in the composition of colonic microbiota at 35 days, determined by 16 S pyrosequencing. Different weaning diets modulated both the microbiota and metabolic phenotype independently of the persistent batch effects. We demonstrate that the environment during the first day of life influences development of the microbiota and metabolic phenotype and thus should be taken into account when interrogating experimental outcomes. In addition, we suggest that intervention at this early time could provide ‘metabolic rescue’ for at-risk infants who have undergone aberrant patterns of initial intestinal colonisation.

Intestinal microbiota and HIV-1 infection

The intestinal microbiota consists of a qualitatively and quantitatively diverse range of microorganisms dynamically interacting with the host. It is remarkably stable with regard to the presence of microorganisms and their roles which, however, can be altered due to pathological conditions, diet composition, gastrointestinal disturbances and/or drug ingestion. The present review aimed at contributing to the discussion about changes in the intestinal microbiota due to HIV-1 infection, focusing on the triad infection-microbiota-nutrition as factors that promote intestinal bacterial imbalance. Intestinal microbiota alterations can be due to the HIV-1 infection as a primary factor or the pharmacotherapy employed, or they can be one of the consequences of the disease.

Immune adaptations that maintain homeostasis with the intestinal microbiota

Humans harbour nearly 100 trillion intestinal bacteria that are essential for health. Millions of years of co-evolution have moulded this human-microorganism interaction into a symbiotic relationship in which gut bacteria make essential contributions to human nutrient metabolism and in return occupy a nutrient-rich environment. Although intestinal microorganisms carry out essential functions for their hosts, they pose a constant threat of invasion owing to their sheer numbers and the large intestinal surface area. In this Review, we discuss the unique adaptations of the intestinal immune system that maintain homeostatic interactions with a diverse resident microbiota.

Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression

Background Inappropriate cross talk between mammals and their gut microbiota may trigger intestinal inflammation and drive extra-intestinal immune-mediated diseases. Epithelial cells constitute the interface between gut microbiota and host tissue, and may regulate host responses to commensal enteric bacteria. Gnotobiotic animals represent a powerful approach to study bacterial-host interaction but are not readily accessible to the wide scientific community. We aimed at refining a protocol that in a robust manner would deplete the cultivable intestinal microbiota of conventionally raised mice and that would prove to have significant biologic validity. Methodology/Principal Findings Previously published protocols for depleting mice of their intestinal microbiota by administering broad-spectrum antibiotics in drinking water were difficult to reproduce. We show that twice daily delivery of antibiotics by gavage depleted mice of their cultivable fecal microbiota and reduced the fecal bacterial DNA load by 400 fold while ensuring the animals' health. Mice subjected to the protocol for 17 days displayed enlarged ceca, reduced Peyer's patches and small spleens. Antibiotic treatment significantly reduced the expression of antimicrobial factors to a level similar to that of germ-free mice and altered the expression of 517 genes in total in the colonic epithelium. Genes involved in cell cycle were significantly altered concomitant with reduced epithelial proliferative activity in situ assessed by Ki-67 expression, suggesting that commensal microbiota drives cellular proliferation in colonic epithelium. Conclusion We present a robust protocol for depleting conventionally raised mice of their cultivatable intestinal microbiota with antibiotics by gavage and show that the biological effect of this depletion phenocopies physiological characteristics of germ-free mice.